ClassID:

20900

A61K38/08 - page 6 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#1501
20180015136
2018-01-18

THERAPEUTIC HOMODIMER AND USES THEREOF

#1502
20180002376
2018-01-04

ANTI-MICROBIAL PEPTIDES AND USES OF SAME

#1503
20180000943
2018-01-04

CONTROLLED-RELEASE FORMULATIONS

#1504
20180000887
2018-01-04

Treatment of Ascites

#1505
20180000784
2018-01-04

PAR4 INHIBITOR THERAPY FOR PATIENTS WITH PAR4 POLYMORPHISM

#1506
20180000126
2018-01-04

Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health

#1507
20170368158
2017-12-28

Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors

#1508
20170362302
2017-12-21

Method and Pharmaceutical Composition for Use in the Treatment of Cancer

#1509
20170362274
2017-12-21

Peptides enhancing neuronal outgrowth and application thereof

#1510
20170360944
2017-12-21

Cardiovascular disease treatment and prevention

#1511
20170360937
2017-12-21

Sprayable Topical Carrier and Composition Comprising Phosphatidylcholine

#1512
20170360897
2017-12-21

Polypeptide and polypeptide complex for suppressing tumor metastasis and treating leukemia as well as preparation method therefor and application thereof

#1513
20170360875
2017-12-21

METHODS FOR TREATING IMMUNE-MEDIATED VIRAL INFECTIONS

#1514
20170355747
2017-12-14

CD154 peptides and methods of inhibiting CD40 interactions with CD154

#1515
20170354736
2017-12-14

Use of alginate formulation for intraincisional drug delivery

#1516
20170354725
2017-12-14

Combinatorial androgen deprivation with an androgen receptor vaccine

#1517
20170349631
2017-12-07

Methods of selecting compstatin mimetics

#1518
20170349630
2017-12-07

Agonists of guanylate cyclase and their uses

#1519
20170349628
2017-12-07

Synthesis of cell penetrating peptides for drug delivery and stem cell applications

#1520
20170348381
2017-12-07

FORMULATION

#1521
20170348380
2017-12-07

INTRAARTICULAR APPLICATION OF PEPSTATIN IN THE CASE OF ARTHROSIS

#1522
20170348379
2017-12-07

Methods and systems for delivery of ZW1 heptapeptide

#1523
20170348378
2017-12-07

METHODS OF TREATING LUNG INFECTION WITH CASPOFUNGIN

#1524
20170348377
2017-12-07

Competitive inhibitors of invariant chain expression and/or ectopic clip binding

#1525
20170340697
2017-11-30

Selective Nox-1 inhibitor peptides and uses thereof

#1526
20170340696
2017-11-30

Chemotherapeutic combinations of cationic antimicrobial peptides and chemotherapeutics

#1527
20170340695
2017-11-30

Methods and compositions for increasing the dose of a chemotherapeutic agent

#1528
20170333565
2017-11-23

TLR9 TARGETED CYTOTOXIC AGENTS

#1529
20170333517
2017-11-23

Compositions and methods for inhibiting fibrosis

#1530
20170326201
2017-11-16

Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same

#1531
20170326199
2017-11-16

USE OF CASPASE-2 INHIBITORS TO TREAT AND PREVENT THE METABOLIC SYNDROME

#1532
20170326198
2017-11-16

strains for producing bioactive peptides having anti-hypertensive and cholesterol-lowering effects

#1533
20170319647
2017-11-09

Combination therapies using cyclosporine and aromatic cationic peptides

#1534
20170319646
2017-11-09

Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist

#1535
20170319645
2017-11-09

COMPOSITIONS AND METHODS FOR TREATING ACUTE RADIATION SYNDROME

#1536
20170319644
2017-11-09

Manufacture of Degarelix

#1537
20170319643
2017-11-09

LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES

#1538
20170313778
2017-11-02

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

#1539
20170313760
2017-11-02

Peptides and combination of peptides for use in immunotherapy against various tumors

#1540
20170313744
2017-11-02

D-enantiomeric peptides derived from D3 and use thereof

#1541
20170312340
2017-11-02

Myristoylated leptin-related peptides and uses thereof

#1542
20170312332
2017-11-02

Inhibitors of mitochondrial fission and methods of use thereof

#1543
20170305993
2017-10-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#1544
20170305992
2017-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1545
20170305967
2017-10-26

METHODS FOR REDUCING CD36 EXPRESSION

#1546
20170304393
2017-10-26

Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance

#1547
20170304390
2017-10-26

Compositions and methods for modulating AT2R activity

#1548
20170304389
2017-10-26

Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan Sulfate Mediated Macropinocytosis

#1549
20170304195
2017-10-26

PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE OR PROTEIN DRUGS

#1550
20170298113
2017-10-19

Synthetic somatostatin receptor ligands

#1551
20170298098
2017-10-19

Conotoxin polypeptide κ-CPTx-bt104, and method for preparation thereof and application thereof

#1552
20170298097
2017-10-19

Peptide derivatives and uses thereof

#1553
20170298094
2017-10-19

Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof

#1554
20170296618
2017-10-19

Brain permeant peptidomimetic beta-secretase 1 inhibitors for the treatment or prophylaxis of neurological disorders or conditions

#1555
20170296617
2017-10-19

Rho associated kinase (ROCK) inhibitors and their use in treating disease

#1556
20170290922
2017-10-12

Activation of adaptive immune processes for the treatment of cancers and infectious diseases

#1557
20170290879
2017-10-12

Methods of treating prostate cancer with GnRH antagonist

#1558
20170290770
2017-10-12

Composition for the treatment of burns, diabetic wounds, other types of wounds and subsequently greatly reduced scarring

#1559
20170283457
2017-10-05

Use of inhibitory peptides for the treatment of inflammatory diseases

#1560
20170281792
2017-10-05

Anti-mesothelin antibodies and immunoconjugates

#1561
20170281720
2017-10-05

Peptidomimetic macrocycles

#1562
20170281719
2017-10-05

Sincalide Formulations

#1563
20170281718
2017-10-05

ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION

#1564
20170281717
2017-10-05

Antimicrobial peptide stimulating cleansing composition

#1565
20170281579
2017-10-05

Methods for rescuing phenobarbital-resistance of seizures by ANA-12 or ANA-12 in combination with CLP290

#1566
20170281548
2017-10-05

Organic Compounds

#1567
20170275334
2017-09-28

LINEAR PEPTIDE ANTIBIOTICS

#1568
20170274037
2017-09-28

PEPTIDES FOR SUPPRESSING INFLAMMATION

#1569
20170267727
2017-09-21

Conjugates of pH Low Insertion Peptide and Monomethyl Auristatins in the Treatment of Solid Tumors

#1570
20170267720
2017-09-21

Opioid peptide

#1571
20170266306
2017-09-21

TARGETED ANTIMICROBIAL MOIETIES

#1572
20170266303
2017-09-21

METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES

#1573
20170266265
2017-09-21

Neurodegenerative disorders

#1574
20170266258
2017-09-21

NF-κB inhibitor composition for skin health

#1575
20170258872
2017-09-14

DPEP-1 binding compositions and methods of use

#1576
20170258868
2017-09-14

Peptides for treating cancer

#1577
20170253632
2017-09-07

Inhibition of pulmonary fibrosis with nutlin-3a and peptides

#1578
20170253631
2017-09-07

Hexapeptide for neuroprotection against a β toxicity

#1579
20170252435
2017-09-07

Combination

#1580
20170252397
2017-09-07

CALCIMIMETICS AND METHODS FOR THEIR USE

#1581
20170252396
2017-09-07

Peptide-based methods for treating pancreatic cancer

#1582
20170247423
2017-08-31

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

#1583
20170246312
2017-08-31

Immunostimulatory method

#1584
20170246240
2017-08-31

Antibacterial peptide and method of treatment using the antibacterial peptide

#1585
20170246239
2017-08-31

ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE

#1586
20170246238
2017-08-31

NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE

#1587
20170239364
2017-08-24

Methods and compositions related to inhibition of viral entry

#1588
20170239317
2017-08-24

ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE

#1589
20170239316
2017-08-24

Method Of Reducing Injury To Mammalian Cells

#1590
20170232116
2017-08-17

Multifunctional metallic nanoparticle-peptide bilayer complexes

#1591
20170232110
2017-08-17

Conjugate for treating malaria

#1592
20170232057
2017-08-17

Opioid peptide

#1593
20170232056
2017-08-17

Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use

#1594
20170226168
2017-08-10

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1595
20170224760
2017-08-10

Compositions and methods for invasive and non-invasive procedural skincare

#1596
20170218021
2017-08-03

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#1597
20170218020
2017-08-03

Peptide compounds for inhibitions of platelet aggregation

#1598
20170218019
2017-08-03

Peptide for inducing multinucleation in cells, and use therefor

#1599
20170216395
2017-08-03

Low-burst polymers and methods to produce polymer

#1600
20170209533
2017-07-27

Antimicrobial compositions and method of use thereof

#1601
20170209526
2017-07-27

Peptide inhibitors of serotonin 5-HTreceptor:PTEN interaction

#1602
20170209525
2017-07-27

Methods and compositions for treating pain

#1603
20170209524
2017-07-27

Methods and compounds to suppress viral genome release and packaging

#1604
20170202902
2017-07-20

Conjugates for immunotherapy

#1605
20170202769
2017-07-20

Methods and compositions for topical delivery for skin care

#1606
20170196933
2017-07-13

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#1607
20170190754
2017-07-06

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#1608
20170189481
2017-07-06

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

#1609
20170189469
2017-07-06

Medical devices

#1610
20170183379
2017-06-29

Drug delivery enhancement agents

#1611
20170182117
2017-06-29

THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC SMALL MOLECULES AND USES THEREOF

#1612
20170174722
2017-06-22

LLP2A-bisphosphonate conjugates for osteoporosis treatment

#1613
20170173109
2017-06-22

Cyclic prosaposin peptides and uses thereof

#1614
20170173108
2017-06-22

Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation

#1615
20170166926
2017-06-15

Targeting peptides for directing adeno-associated viruses (AAVs)

#1616
20170165371
2017-06-15

NOVEL SYNTHESIS OF POTENTIAL ESTER PRODRUGS

#1617
20170165318
2017-06-15

Method and compositions comprising a CT20 peptide

#1618
20170165317
2017-06-15

METHOD FOR MITIGATING OR ALLEVIATING SYNAPTIC AND COGNITIVE DEFICITS

#1619
20170165204
2017-06-15

Sustained-release composition and method for producing the same

#1620
20170158750
2017-06-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#1621
20170158736
2017-06-08

Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

#1622
20170157217
2017-06-08

Use of endostatin peptides for the treatment of fibrosis

#1623
20170157210
2017-06-08

CAPCNA peptide therapeutics for cancer

#1624
20170157197
2017-06-08

Methods of using GM604 in modulating ALS disease biomarkers leading to prognosis and therapeutic treatment for ALS disease

#1625
20170151306
2017-06-01

Dosing regimens for echinocandin class compounds

#1626
20170145073
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#1627
20170145072
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#1628
20170145055
2017-05-25

PEPTIDE INHIBITORS OF CASPASE 2 ACTIVATION

#1629
20170143787
2017-05-25

CHEMOKINE RECEPTOR ANTAGONIST AND ITS COMBINATIONAL THERAPY

#1630
20170143785
2017-05-25

Peptide as absorption enhancer and composition containing same

#1631
20170143703
2017-05-25

Toxic RNA inhibitors self-assembled in situ

#1632
20170136095
2017-05-18

Methods of treatment using a pentapeptide derived from the C-Terminus of Glucagon-Like Peptide 1 (GLP-1)

#1633
20170136040
2017-05-18

Synthetic bile acid compositions and methods

#1634
20170131285
2017-05-11

METHODS AND COMPOSITIONS FOR DIAGNOSING, MONITORING AND TREATING CANCER

#1635
20170128520
2017-05-11

Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators

#1636
20170121369
2017-05-04

Inhibitors of metastasis

#1637
20170119910
2017-05-04

Enzymatically responsive magnetic particles and their use

#1638
20170119733
2017-05-04

Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases

#1639
20170114098
2017-04-27

PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF

#1640
20170112938
2017-04-27

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#1641
20170112895
2017-04-27

Pharmaceutical formulations of desmopressin

#1642
20170112894
2017-04-27

Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment

#1643
20170112748
2017-04-27

N-ACYLPEPTIDE DERIVATIVES AND THEIR USES

#1644
20170107253
2017-04-20

Neuroprotective composition and method of use

#1645
20170106085
2017-04-20

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB

#1646
20170100491
2017-04-13

AURISTATIN TYRAMINE PHOSPHATE SALTS AND AURISTATIN AMINOQUINOLINE DERIVATIVES AND PRODRUGS THEREOF

#1647
20170100453
2017-04-13

Chemical induction of lactation in prepubescent non-human mammals

#1648
20170100452
2017-04-13

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AXONAL AND NEURONAL DEGENERATION

#1649
20170096451
2017-04-06

INHIBITION OF GLIADIN PEPTIDES

#1650
20170095560
2017-04-06

Low-burst polymers and methods to produce polymers

#1651
20170088582
2017-03-30

Macrocyclic broad spectrum antibiotics

#1652
20170087257
2017-03-30

Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma

#1653
20170079920
2017-03-23

Technology for the Preparation of Microparticles

#1654
20170079895
2017-03-23

Peptide nanoparticles and uses therefor

#1655
20170073384
2017-03-16

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

#1656
20170073370
2017-03-16

Broad spectrum antibiotics

#1657
20170073369
2017-03-16

METHODS FOR THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA AND RELATED DISORDERS

#1658
20170072052
2017-03-16

Compositions for stimulation of mammalian innate immune resistance to pathogens

#1659
20170072013
2017-03-16

Retro-inverso analogs of spadin display increased antidepressant effects

#1660
20170072008
2017-03-16

Autoassembling peptides for the treatment of pulmonary bulla

#1661
20170071905
2017-03-16

Compositions and methods for drug-sensitization or inhibition of a cancer cell

#1662
20170071502
2017-03-16

Methods and apparatus for guiding medical care based on detected gastric function

#1663
20170066830
2017-03-09

Monoclonal antibodies against HER2 epitope and methods of use thereof

#1664
20170065666
2017-03-09

Composition comprising peptides made by strains

#1665
20170065665
2017-03-09

Composition comprising peptides made by strains

#1666
20170065662
2017-03-09

Compositions targeting the interaction domain between p27KiP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity

#1667
20170058002
2017-03-02

γ-AApeptides with potent and broad-spectrum antimicrobial activity

#1668
20170056466
2017-03-02

JNK inhibitor molecules for treatment of various diseases

#1669
20170051014
2017-02-23

Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same

#1670
20170049902
2017-02-23

Sulfur-containing polymers from hexahydrotriazine and dithiol precursors as a carrier for active agents

#1671
20170049849
2017-02-23

Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof

#1672
20170049848
2017-02-23

Target for Firmicutes and Related Bacteria: The PRP Protease

#1673
20170049847
2017-02-23

Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same

#1674
20170049846
2017-02-23

Methods of treating lung infection with caspofungin

#1675
20170044212
2017-02-16

COMPOUND FOR TREATING SEQUELAE OF ISCHEMIC CEREBRAL STROKE

#1676
20170043034
2017-02-16

METHODS OF USING ANTI-STEAP1 ANTIBODIES AND IMMUNOCONJUGATES

#1677
20170043030
2017-02-16

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#1678
20170042970
2017-02-16

Use of peptide for treating angiogenesis-related diseases

#1679
20170042964
2017-02-16

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

#1680
20170035884
2017-02-09

AQUEOUS GELLING COMPOSITIONS OF SOLUBLE ACTIVE PHARMACEUTICAL PEPTIDES PROVIDING MODIFIED RELEASE

#1681
20170035851
2017-02-09

Compositions And Methods For Treating Glioma

#1682
20170035833
2017-02-09

Method of treating prostate cancer with GnRH antagonist

#1683
20170035832
2017-02-09

Uses of hypoxia-inducible factor inhibitors

#1684
20170035734
2017-02-09

PAR4 inhibitor therapy for patients with PAR4 polymorphism

#1685
20170035702
2017-02-09

Compositions and methods for delivery of kinase inhibiting peptides

#1686
20170022321
2017-01-26

Polyethylene glycol substituted acyl borates

#1687
20170020956
2017-01-26

Peptides having anti-inflammatory properties

#1688
20170014495
2017-01-19

ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF

#1689
20170014473
2017-01-19

AMPHIPHILIC PEPTIDE MATRICES FOR TREATMENT OF OSTEOPOROSIS

#1690
20170014470
2017-01-19

Sincalide Formulations

#1691
20170014469
2017-01-19

METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS

#1692
20170008928
2017-01-12

NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF

#1693
20170008927
2017-01-12

ARTIFICIAL CATALYST SYSTEM SUBSTITUTABLE FOR IN VIVO ACYLATION FUNCTION

#1694
20170007708
2017-01-12

Glycotargeting therapeutics

#1695
20170007696
2017-01-12

Supramolecular hydrogel of fMLF-based molecules and use thereof

#1696
20170007687
2017-01-12

Peptide vaccine therapy for treatment of FRα-expressing tumors

#1697
20170007666
2017-01-12

Compositions and methods for treating diabetes

#1698
20170007573
2017-01-12

Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances

#1699
20170007511
2017-01-12

FOAM COMPOSITIONS, AEROSOL PRODUCTS, AND METHODS OF USING THE SAME TO IMPROVE SENSORY BENEFITS TO THE SKIN

#1700
20170002043
2017-01-05

Peptides and methods and uses thereof for preventing retinal disorders

#1701
20170000842
2017-01-05

SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

#1702
20170000696
2017-01-05

METHODS OF APPLYING A HIGH DOSE OF A SKIN CARE ACTIVE TO SKIN WITH IMPROVED SENSORY BENEFITS TO THE SKIN

#1703
20160375177
2016-12-29

Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing

#1704
20160375130
2016-12-29

Immunotherapeutic composition and uses thereof

#1705
20160375114
2016-12-29

Newly identified peptides for use in the induction of oral tolerance in young mammals

#1706
20160375089
2016-12-29

MATERIALS AND METHODS FOR THE TREATMENT OF CELIAC DISEASE

#1707
20160375056
2016-12-29

METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS

#1708
20160374331
2016-12-29

ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY

#1709
20160367637
2016-12-22

Methods of treating mild brain injury

#1710
20160362466
2016-12-15

Peptides having osteoblast growth-promoting activity and use thereof

#1711
20160361433
2016-12-15

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1712
20160361379
2016-12-15

Use of CHEC Peptides to Treat Neurological and Cardiovascular Diseases and Disorders

#1713
20160361378
2016-12-15

Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain

#1714
20160361376
2016-12-15

Conjugates for treating diseases caused by PSMA expressing cells

#1715
20160355555
2016-12-08

Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

#1716
20160355551
2016-12-08

Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome

#1717
20160354480
2016-12-08

Activated neurotensin molecules and the uses thereof

#1718
20160354427
2016-12-08

METHODS FOR INDUCING EPITHELIAL CANCER CELL SENESCENCE

#1719
20160354426
2016-12-08

METHODS OF DIAGNOSING AND TREATING ASTHMA

#1720
20160354409
2016-12-08

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

#1721
20160347815
2016-12-01

Peptide mimotopes of claudin 18.2 and uses thereof

#1722
20160346346
2016-12-01

Synthetic peptide that increases radiosensitivity of tumor cells and use of same

#1723
20160340442
2016-11-24

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

#1724
20160339075
2016-11-24

Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs

#1725
20160339065
2016-11-24

Methods for Treating Autism Spectrum Disorder and Associated Symptoms

#1726
20160334425
2016-11-17

Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders

#1727
20160331916
2016-11-17

Intranasal administration

#1728
20160331810
2016-11-17

Compositions and methods for treating melanoma

#1729
20160331805
2016-11-17

Treatment of ocular disorders with anti-connexin proteins and mimetics

#1730
20160331801
2016-11-17

USE OF CASPASE-2 INHIBITORS TO TREAT AND PREVENT THE METABOLIC SYNDROME

#1731
20160331800
2016-11-17

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#1732
20160331797
2016-11-17

Dermatological composition based on algae and olive leaf extracts

#1733
20160331708
2016-11-17

MEANS AND METHODS FOR INCREASING ANTIBIOTIC ACTIVITY

#1734
20160326216
2016-11-10

HCV PROTEASE INHIBITORS AND USES THEREOF

#1735
20160324918
2016-11-10

TREATMENT OF LEAKY OR DAMAGED TIGHT JUNCTIONS AND ENHANCING EXTRACELLULAR MATRIX

#1736
20160324843
2016-11-10

Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients

#1737
20160318975
2016-11-03

Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin

#1738
20160317616
2016-11-03

Pharmaceutical compositions targeting WNT pathway proteins

#1739
20160317604
2016-11-03

Methods for reducing oxidative damage

#1740
20160310683
2016-10-27

Intranasal administration

#1741
20160310615
2016-10-27

SPRAY ON HEMOSTATIC SYSTEM

#1742
20160310601
2016-10-27

Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions

#1743
20160310558
2016-10-27

USES OF KAPPA OPIOID SYNTHETIC PEPTIDE AMIDES

#1744
20160304561
2016-10-20

Glycopeptide compositions and uses thereof

#1745
20160303239
2016-10-20

Sprayable topical carrier and composition comprising phosphatidylcholine

#1746
20160303182
2016-10-20

USE OF PEPTIDES IN ANTIBIOTIC RESISTANCE

#1747
20160297851
2016-10-13

BROAD SPECTRUM ANTIBIOTIC ARYLOMYCIN ANALOGS

#1748
20160296660
2016-10-13

Compositions and methods for promoting hemostasis and other physiological activities

#1749
20160296605
2016-10-13

Methods and compositions for treating Huntington's disease

#1750
20160296592
2016-10-13

Methods and Compositions for the Treatment of Proteinuric Diseases

#1751
20160296590
2016-10-13

METHOD OF TREATING OR PREVENTING EPILEPSY OR SEIZURES USING ONE OR MORE NEURAL REGENERATION PEPTIDES

#1752
20160296587
2016-10-13

Treatment of left ventricular non-compaction and dilated cardiomyopathy by inhibiting melanocortin receptor four

#1753
20160287704
2016-10-06

Topical Pharmaceutical Cosmetic and Disinfectant Compositions Comprising Phosphatidylcholine

#1754
20160287673
2016-10-06

COMPOSITIONS AND METHODS FOR TREATING CORNEAL EPITHELIAL WOUND

#1755
20160287663
2016-10-06

Methods of treating cancers with peptide-based modulators

#1756
20160280759
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1757
20160280758
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1758
20160280757
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1759
20160280752
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1760
20160280738
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1761
20160279217
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1762
20160279214
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1763
20160279196
2016-09-29

Anti-SSX-2 T cell receptors and related materials and methods of use

#1764
20160279194
2016-09-29

Histatin for corneal wound healing and ocular surface disease

#1765
20160279193
2016-09-29

Immunosuppressive agents and their use in therapy

#1766
20160279189
2016-09-29

Delivery of drugs

#1767
20160272678
2016-09-22

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

#1768
20160271204
2016-09-22

CEACAM based antibacterial agents

#1769
20160263260
2016-09-15

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

#1770
20160263179
2016-09-15

Softgel of NLKJ for treating prostate diseases

#1771
20160257746
2016-09-08

Antibodies specific for TROP-2 and their uses

#1772
20160257717
2016-09-08

Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

#1773
20160257712
2016-09-08

Integrin interaction inhibitors for the treatment of cancer

#1774
20160257711
2016-09-08

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#1775
20160256550
2016-09-08

Functional, cross-linked nanostructures for tandem optical imaging and therapy

#1776
20160256518
2016-09-08

Peptides for inhibiting angiogenesis

#1777
20160256517
2016-09-08

COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR

#1778
20160256516
2016-09-08

Phosphorylcholine conjugates and uses thereof

#1779
20160251397
2016-09-01

Akt-specific capture agents, compositions, and methods of using and making

#1780
20160244508
2016-08-25

Use of endostatin peptides for the treatment of fibrosis

#1781
20160237117
2016-08-18

Connective tissue stimulating peptides

#1782
20160235806
2016-08-18

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

#1783
20160235675
2016-08-18

Technology for the Preparation of Microparticles

#1784
20160229890
2016-08-11

Peptides and analogs for use in the treatment of oral mucositis

#1785
20160228621
2016-08-11

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

#1786
20160228520
2016-08-11

Compositions and methods for treating granulomatosis with polyangiitis

#1787
20160228504
2016-08-11

S100 based treatment of cardiac power failure

#1788
20160228499
2016-08-11

Therapy for subarachnoid hemorrhage and ischemia

#1789
20160228493
2016-08-11

Aminostatin derivatives for the treatment of arthrosis

#1790
20160228492
2016-08-11

Inhibitors of valosin-containing protein and methods of use

#1791
20160228488
2016-08-11

NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING

#1792
20160222078
2016-08-04

VIP fragments and methods of use

#1793
20160222061
2016-08-04

Polymyxin derivatives and their use in combination therapy together with different antibiotics

#1794
20160220692
2016-08-04

TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY

#1795
20160220682
2016-08-04

Sustained release polymer

#1796
20160220651
2016-08-04

Immunogenic tumor associated stromal cell antigen peptides and methods of their use

#1797
20160220628
2016-08-04

Method of treating diseases

#1798
20160220489
2016-08-04

Intranasal Formulation for the Treatment of Cardiopulmonary Resuscitation (CPR), Cardiac Life Support (CLS), Anaphylaxis and/or Anaphylactoid Reactions

#1799
20160220486
2016-08-04

Stable liquid formulation of AMG 416 (etelcalcetide)

#1800
20160219880
2016-08-04

Peptoid oligomers, pharmaceutical compositions and methods of using the same